<unk>  is indicated in combination with dexamethasone for the treatment of adults with relapsed or refractory multiple myeloma, with relapsed or refractory multiple myeloma who have received at least four prior lines of therapy and whose disease is refractory to at least one proteasome inhibitor, one immunomodulatory agent, and one CD-38 directed monoclonal antibody.
Melphalan flufenamide
Normustine
Ifosfamide
Fluorouracil
Carmustine
GemOx
Topotecan
Etoposide